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Embryonic stem cells (ESCs) repress the expression
of exogenous proviruses and endogenous retrovi-
ruses (ERVs). Here, we systematically dissected the
cellular factors involved in provirus repression in em-
bryonic carcinomas (ECs) and ESCs by a genome-
wide siRNA screen. Histone chaperones (Chaf1a/
b), sumoylation factors (Sumo2/Ube2i/Sae1/Uba2/
Senp6), and chromatin modifiers (Trim28/Eset/At-
f7ip) are key determinants that establish provirus
silencing. RNA-seq analysis uncovered the roles
of Chaf1a/b and sumoylation modifiers in the re-
pression of ERVs. ChIP-seq analysis demonstrates
direct recruitment of Chaf1a and Sumo2 to ERVs.
Chaf1a reinforces transcriptional repression via its
interaction with members of the NuRD complex
(Kdm1a, Hdac1/2) and Eset, while Sumo2 orches-230 Cell 163, 230–245, September 24, 2015 ª2015 Elsevier Inc.trates the provirus repressive function of the canon-
ical Zfp809/Trim28/Eset machinery by sumoylation
of Trim28. Our study reports a genome-wide atlas
of functional nodes that mediate proviral silencing
in ESCs and illuminates the comprehensive, inter-
connected, and multi-layered genetic and epigenetic
mechanisms by which ESCs repress retroviruses
within the genome.INTRODUCTION
The expression of proviruses and endogenous retroviruses
(ERVs) is restricted in pluripotent stem cells (Feuer et al., 1989;
Niwa et al., 1983; Teich et al., 1977). This silencing has likely
evolved for the protection of germline cells from insertional muta-
genesis (Gaudet et al., 2004; Walsh et al., 1998). The expression
and DNA methylation profiles of the Moloney murine leukemia
virus (MMLV) have been investigated in embryonic carcinoma
Figure 1. Genome-wide siRNA Screen for Regulators of Proviral Silencing in Mouse F9 ECs
(A) Schematic of the proviral MMLV-Gfp reporter assay. The map of the proviral reporter is shown (upper panel). LTR (black) indicates the long terminal repeats,
while PBS (blue) represents the primer binding site. F9 cells were infected with the reporter virus and subjected to reverse transfection with the siRNA library in
384-well plates. A representative image for Gfp fluorescence (green) and nuclear Hoechst 33342 staining (blue) in a 384-well plate is shown. In each 384-well
plate, non-targeting siRNA control (siNT) and positive control siRNA against Trim28 and Eset (siTrim28 and siEset) were added.
(legend continued on next page)
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cells (ECs) and embryonic stem cells (ESCs) (Niwa et al., 1983).
DNA methylation is thought to repress the expression of viral
genes in differentiated cells, while repression in pluripotent cells
is mediated by both cis-acting de novo methylation of the inte-
grated proviruses (Gaudet et al., 2004; Walsh et al., 1998) and
trans-acting transcriptional repressors (Petersen et al., 1991;
Stewart et al., 1982; Walsh et al., 1998; Wolf et al., 2008a; Wolf
and Goff, 2007).
It has been reported that many ERVs affect cellular gene activ-
ity by acting as alternative promoters or enhancers (Peaston
et al., 2004). For example, MERVL is transiently activated during
the mouse two-cell (2C) stage, regulating the expression of 2C-
specific genes (Macfarlan et al., 2012). ERVsmay also function in
the reprogramming of somatic cells into induced pluripotent
stem cells (iPSCs). Specific ERVs are re-activated during the
reprogramming process, while other classes of ERVs have to
be silenced to attain complete reprogramming (Friedli et al.,
2014; Wissing et al., 2012). Together, these studies suggest
that proviral silencing is a characteristic of the pluripotent state,
and the precise expression of ERVs have critical roles during
embryogenesis and development.
Various studies have implicated diverse epigenetic mecha-
nisms in the silencing of retroviruses and ERVs. Repression is
thought to be dependent on a conserved sequence element
termed the primer binding site (PBS). Factors such as Zfp809,
Trim28, and Eset are responsible for mediating the H3K9me3
repressive silencing mechanism (Friedli et al., 2014; Rowe
et al., 2010; Wolf and Goff, 2007, 2009; Wolf et al., 2008b).
Eset was shown to be involved in the repression of retroviruses
and subfamilies of ERVs, predominantly of class I and II ERVs
(Karimi et al., 2011; Matsui et al., 2010). More recently, viral-
silencing factors such as the zinc finger protein Yin yang 1
(Yy1), Erb3 binding protein 1 (Ebp1), and the polycomb repres-
sive complex 2 (PRC2) catalytic subunit Ezh2 (Schlesinger
et al., 2013; Schlesinger and Goff, 2013; Wang et al., 2014)
have been described. Other studies reporting the role of host
factors governing ERVs in model organisms, such as Saccharo-
myces cerevisiae (Maxwell and Curcio, 2007) have also pro-
vided critical evolutionary insight into the dynamics of retroviral
regulation.
Despite many efforts to identify the factors involved, many
components of the epigenetic machinery required for stable
silencing of proviruses and ERVs remains poorly characterized.
To advance our understanding, we developed a powerful high-
throughput screening approach based on a provirus MMLV-
Gfp reporter (Schlesinger et al., 2013) and genome-wide small
interfering RNA (siRNA) knockdown. Our screen identified 303
determinants of viral silencing in mouse ESCs with high confi-(B) Dot plot for genome-wide siRNA screen. A cut-off threshold was set at 0.3
reactivation.
(C) Representative images ofGfp rescue for selected hits from the genome-wide s
(D) Secondary siRNA screen for 74 genes. Results for reactivation of proviral Gfp
represents the level of reactivation of Gfp and mCherry reporters respectively. S
criteria and experimental design.
(E) Validation of candidate genes using shRNA knockdown.Gfp signal was detecte
mean ± SEM from independent replicate experiments.
See also Figure S1 and Table S1.
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determinants mediating proviral silencing in pluripotent embry-
onic stem cells.
RESULTS
Unbiased Genome-wide siRNA Screen for Determinants
of Proviral Silencing in Embryonic Carcinoma Cells
To define the factors involved in the silencing process, we devel-
oped a high-throughput screening approach based on a provirus
MMLV-Gfp reporter and siRNAknockdown in F9 ECs (Figure 1A).
F9 cells were infected with the MMLV-Gfp virus and then reverse
transfected with siRNA in 384-well plates. Expression of Gfp on
day 4 post-infection indicated retrovirus activation.
We first confirmed the sensitivity of the reporter assay via
knockdown of canonical repressive genes Trim28 and Eset.
Consistently, imaging, and fluorescence-activated cell sorting
(FACS) analysis showed that knockdown of both factors dramat-
ically relieved the repression of retroviral Gfp (Figures S1A and
S1B). We next carried out a pilot screen on the kinome siRNA li-
brary in F9 cells, using non-targeting (siNT) Trim28 and Eset
siRNAs as controls. The kinome library screen was analyzed
by Z-prime score (Figures S1C–S1F). From the screen, we iden-
tified both known (Trim28 and Cdk9) and undetermined factors
(Chuk, Epha4,Csnk1e, Sgpp1, andNpp4a) responsible for retro-
virus silencing (Figure S1G). Cdk9 was previously reported to
interact with HIV-1 Tat protein and regulate HIV-1 transcription
(Kao et al., 1987).
Next, we carried out a whole genome siRNA screen targeting
20,000 genes in F9 cells (Figure 1A). Candidates that caused
excessive cell death upon siRNA knockdown were excluded
using a stringent nuclei number cut-off threshold. Based on
the normalized Gfp signal cut-off value, which short-listed fac-
tors that had values larger than 2 SDs from the mean of
the negative controls (Figure 1B), 650 factors were short-listed
(Table S1). Among the hits are factors previously implicated
in retroviral silencing process, such as Eset, Zfp809, Yy1,
and Trim28. In addition, new candidates identified include
Ube2i, Pcna, Hist1h3c, Mphosph8, Adcy6, Sh3bp1, and
Thyn1 (Figure 1C).
To validate the genome-wide siRNA screen, we performed
secondary siRNA screens utilizing the MMLV-Gfp reporter and
an independent MMLV-mCherry reporter. We observed strong
correlation between the two reporters (Figure 1D). To minimize
possible non-specific effects from the pooled siRNA, we de-
signed two pairs of short hairpin RNAs (shRNAs) for 31 candidate
genes and three non-candidate genes. shRNA validation was
performed in F9 cells, followed by FACS analysis of Gfp7 (dotted line). Candidate genes above the threshold showed significant Gfp
creen. Gfp (green) and Hoechst 33342 staining of the nucleus (blue) are shown.
or mCherry reporters are shown as heatmaps. Intensity of green or red color
ee Supplemental Experimental Procedures for details on the gene selection
d by FACS. The percentage ofGfp activation is shown on the y axis. Values are
Figure 2. Bioinformatics Analyses for the Genome-wide siRNA Screen and the ESC Specificity of the Candidate Genes
(A) Interactome analysis. Cellular localization of the hits is indicated.
(B) Interactions observed in hits of different ranking tiers. Localization of hits is indicated as in (A). P values and number of interactions are indicated.
(C and D) Validation of MMLV-Gfp rescue by siRNA knockdown of the top candidates in D3 and E14 ESCs. Non-targeting siRNA (siNT) and siRNA targeting non-
hits (Dmnt1, Ehmt2, Senp7) were selected as controls. (C) Representative images of Gfp rescue by siRNA knockdown of the indicated hits. Gfp (green) and
Hoechst 33342 nucleus staining (blue) are shown. (D) Bar chart graphs forGfp activation. RelativeGfp signal is shown on the y axis. Values are mean ± SEM from
independent replicate experiments.
(E) Representative images of MMLV-mCherry and MMLV-Gfp rescue by siRNA knockdown of selected top hits in MEF and 3T3 cells.mCherry (red), Gfp (green)
and Hoechst 33342 nucleus staining (blue) are shown.
(legend continued on next page)
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expression. shRNA knockdown efficiencies were confirmed by
qPCR (Figure S1H) and western blot analysis for selected genes
(Figure S1I). Notably, we observed robust Gfp reactivation for the
majority of top hits (Figure 1E). From the results of secondary
siRNA and shRNA screens, we focused on the top 303 hits
that were highly corroborative with the primary screen and are
considered high confidence candidates.
Network Analysis of the Candidates Reveals Multiple
Interacting Pathways Involved in Proviral Silencing
WeperformedGeneOntology (GO), KEGG, and Interpro analysis
(Huang et al., 2009) on the top 303 hits and elucidated 148 sta-
tistically enriched biological processes and pathways, including
chromatin modification and organization, protein sumoylation
and phosphorylation, regulation of transcription, DNA replica-
tion, DNA repair, and methylation (Figure S2A; Table S2).
Protein-protein interaction analysis of the high confidence hits
demonstrates tight and dense interaction between the candidate
proteins (Figure 2A). In addition, cellular component analysis re-
vealed that the candidates were widely distributed in different
sub-cellular fractions (Figures 2A and S2B). These suggest that
proviral silencing is controlled by multilayered machineries
involving components of different cellular pathways and with
varied cellular localization.
Candidate Genes Are Potent Repressors of Provirus
Expression in Embryonic Stem Cells
We analyzed the expression profiles of the candidate genes in
over 100 cell lines using the cTen database (Shoemaker et al.,
2012). The majority of candidate genes are highly expressed in
embryonic stem cell lines and are low in other tissue-specific
cell lines (Figure S2C). The expression of selected candidates
was further tested in the mouse ESC lines E14 and D3, mouse
EC lines F9 and P19, as well as in differentiated mouse embryo
fibroblasts (MEFs). Consistent with cTen enrichment scores,
qPCR analyses showed embryonal and stem cell-specific
expression of the candidates (Figure S2D).
To further interrogate the function of our candidate hits, we
performed network analysis of the hits based on their tiered
ranking. We observed greater interactions among our top 50
candidates, although the lower ranked hits also exhibited spe-
cific interactions indicative of their biological significances (Fig-
ure 2B). Among the top 20 hits are the histone chaperones
(Chaf1a/b), sumoylation modification genes (Ube2i, Sumo2,
Uba2, Sae1, and Senp6), and chromatin-bound factors (Eset,
Atf7ip, Zfp809, Trim28). To test the functional specificity of these
strong candidates in mESCs, we conducted siRNA and shRNA
knockdowns in two mESC lines E14 and D3 and in two differen-
tiated cell types, 3T3 and MEFs. The results of the Gfp reporter
rescue assay from mESC lines corroborate well with the primary
screen done in F9 cells (Figures 2C, 2D, and S2E). In contrast,
MMLV-driven expression of Gfp or mCherry was high in 3T3
and MEFs at the outset and knockdown of candidate genes(F) Representative images for Oct4 and Nestin staining on E14 cells (upper pane
(G) MMLV-Gfp rescue in E14-derived neural cells by siRNA knockdown of selecte
from independent replicate experiments.
See also Figure S2 and Table S2.
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cell lines (Figures 2E and S2F).
To further assess the ESC specificity of our candidates, we
differentiated E14 and D3 cells via embryoid body (EB) formation
and neural differentiation (Ying et al., 2003). The differentiated
cells lost their ESC-specific morphologies and pluripotency
markers and expressed high levels of differentiation genes (Fig-
ures 2F and S2G). Consistent with a previous report, the MMLV
virus remain silenced in differentiated ESCs (Niwa et al., 1983).
None of the candidate gene knockdowns in the differentiated
cells could rescue MMLV-Gfp reporter expression (Figures 2G
and S2H), suggesting that alternative or additional silencing
pathways are active in these cells. Relative copy number of inte-
grated reporters in E14 and the differentiated cells was indistin-
guishable, ruling out the possibility of reduced viral integration in
the latter (Figures S2I and S2J). In addition, knockdown of the
top hits did not reduce provirus integration efficiency in E14 cells
(Figure S2K). Of note, we observed no significant change in Gfp
signal driven by an integrated non-LTR reporter (PiggyBac-CAG-
Gfp) upon knockdown of the top hits (Figures S2L and S2M). This
strongly suggests that the mode of proviral regulation by the fac-
tors is transcriptional or epigenetic.
Chaf1a/b and Sumoylation Modification Complex Play
Critical Roles in Regulating ERVs
To evaluate the roles of Chaf1a/b and the sumoylation factors in
ERV regulation, we measured ERV expression by qPCR upon
depletion of the candidates. Consistent with a previous study,
Trim28 knockdown elicited reactivation of IAP elements in
ESCs (Figure S3A) (Rowe et al., 2010). Intriguingly, we found up-
regulation of class I (GLN), class II (MMERVK10c), and class III
(MERVL) elements following depletion of the factors from the
Caf1 complex, sumoylation complex, and Atf7ip (Figure S3A).
Notably, Northern blot assays confirmed increased transcription
of MERVL, but not of IAP and MusD elements in Chaf1a/b
depleted E14 cells (Figure S3C). Meanwhile, knockdown of
selected weaker candidates also showed consistent de-repres-
sion of MERVL but not of the other ERVs (Figure S3B).
To further delineate the regulatory roles of the candidates on
ERVs, we performed genome-wide RNA sequencing (RNA-
seq) of Chaf1a/b-, Sumo2-, Sae1-, Ube2i-, Ube2-, Senp6-,
Trim28-, Eset-, and Atf7ip-depleted cells. Transcriptomic ana-
lyses revealed significant de-repression of several families of
ERVs upon depletion of each factor (Figure 3A; Table S3). In
contrast to their effects on global gene expression (Figure S3D),
the majority of the ERV targets are upregulated upon shRNA
knockdown (Figure 3B). Together, these suggest an ERV-spe-
cific repressive function of the candidates.
Next, we evaluated the ERV classes regulated by the candi-
dates. Chaf1a/b depletion resulted in the de-repression of large
numbers of Class III ERVs, while the sumoylation and canonical
factors regulated more Class II ERVs (Figure 3C). Cluster anal-
ysis detected strong correlation of ERV regulation within thel) and E14 ESCs derived differentiated neural cells (lower panel).
d top hits. Relative Gfp signal is shown on the y axis. Values are mean ± SEM
Figure 3. Histone Modifiers and Sumoylation Factors Regulate ERVs in Mouse Embryonic Stem Cells
(A) Frequency histogram of gene expression from RNA-seq data after Chaf1a, Sumo2, Trim28, or Eset depletion in E14 cells. Log2 fold change of expression
levels is shown on the x axis. The number of genes at a given expression level is shown on the y axis.
(B) Percentage stacked columns indicating the up or downregulation of ERVs upon the depletion of the indicated factors.
(C) Percentage stacked columns indicating the classes of upregulated ERVs upon the depletion of the indicated factors.
(D) Clustering analysis of the indicated RNA-Seq libraries based on differential ERV expression. Heatmap color intensity signifies the correlation strength between
0 (red-high similarity) to 0.8 (yellow-high difference).
(E and F) Genome-wide de-regulation of ERVs in E14 cells after depletion of the indicated genes. RNA-seq data for RNAi samples and the shVector control were
used to calculate the Log2 fold change values. Red dots indicate the elements with significantly increased expression.
(G and H) Venn diagrams demonstrating the number of commonly and differentially upregulated ERVs among the depletion of indicated factors.
See also Figure S3 and Table S3.
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Chaf1a/b, sumoylation factors, and the chromatin binding fac-
tors Trim28, Atf7ip, and Eset (Figure 3D), whereas the anal-
ysis of global gene expression displayed a different pattern
(Figure S3E).
Remarkably, Trim28 shares significant similarity with both the
Chaf1a/b and sumoylation factors in their ERV regulation (Fig-
ure 3D), suggesting overlapping mechanisms. ERVs controlled
by Atf7ip overlapped extensively with the ones regulated by
Trim28 or Eset (Figure S3F), indicating that Atf7ip may be integral
to the canonical Krab-Zfp/Trim28/Eset machinery. Atf7ip was
shown to be a co-factor of Eset that helps in facilitating the con-
version of H3K9me2 to H3K9me3 (De Graeve et al., 2000; Wang
et al., 2003). Furthermore, the ERVs regulated by Chaf1a over-
laps significantly with the ones regulated by Chaf1b (Figures
3D, 3E and 3G), but differ significantly from those controlled by
Sumo2 (Figures 3F and 3H). One key feature of the cluster of su-
moylation genes is the strong correlation between the factors in
the specific control of their ERV targets as shown by the tight
pairwise correlation (Figure 3E). This suggests a coordinated
mechanism involvingmultiple members of the same sumoylation
pathway. Interestingly, most ERVs regulated by Sae1 and Ube2i
are part of the larger number of ERVs governed by Sumo2, sug-
gesting a central role for Sumo2 in this sumoylation process (Fig-
ure 3G). It is noteworthy that many ERVs regulated by Sumo2 are
similarly governed by Trim28 (Figures 3F and 3H).
To validate the RNA-seq data, we performed qPCR on each
class of ERVs (Figure S3G). Consistently, RLTR6_Mm/ERV1
was specifically regulated by the sumoylation factors, while ET-
nERV3-int/ERVK was regulated by Atf7ip, Eset, and Chaf1a, but
not by the sumoylation factors. MT2_Mm/ERVL was sharply up-
regulated upon the depletion of Chaf1a/b, while expression was
less perturbed with depletion of factors from the other two clus-
ters. Finally, LTR16D was upregulated upon depletion of genes
from all the clusters.
Chaf1a and Sumo2 Are Directly Recruited to ERVs
We wanted to determine whether Chaf1a and Sumo2 are en-
riched on genomic ERVs. First, we introduced 3xHA tags at
the 30end of the endogenous Chaf1a locus in F9 cells using
CRISPR/Cas technology (Figure S4A). The Chaf1a-3xHA cell
line was characterized by shRNA knockdown, which led to the
specific reduction of Chaf1a-3xHA as measured by western
blot and immunostaining (Figure S4B). In addition, a Zfp809-
3xHA overexpression D3 cell line was also established and simi-
larly characterized (Figure S4C). The reliability of the Sumo2
antibodies used for chromatin immunoprecipitation (ChIP) was
confirmed with knockdown of Sumo2 followed by western blot
analysis (Figure S4D). To survey the global binding profiles
of Chaf1a, Sumo2, Trim28, and Zfp809 on genomic ERV loci,
we performed ChIP sequencing (ChIP-seq). The quality of
the ChIP DNA was determined by qPCR and motif analysis.
Zfp809-3xHA ChIP-qPCR yielded high enrichment at proline
PBS site (Figures S4E and S4F), and Trim28 ChIP-qPCR showed
strong binding at a previously reported target gene Ptpn18 (Fig-
ure S4G) (Hu et al., 2009).
ChIP-seq analysis revealed that both Chaf1a and Sumo2 are
recruited to loci of members of several classes of ERVs (Fig-
ures 4A and 4B; Table S4). We next asked if the bound ERV236 Cell 163, 230–245, September 24, 2015 ª2015 Elsevier Inc.loci are enriched for any histone modifications. We compared
the Chaf1a, Sumo2, Trim28, and Zfp809 ChIP-seq data with
publicly available datasets of histone marks and Eset ChIP-
seq. Although the majority of ERVs bound by Chaf1a are en-
riched with H3K9me3 (Figure 4C), the H3K9me3 is of lower
intensity compared to that of Trim28, Zfp809, and Sumo2
bound ERVs (Figure 4C). Intriguingly, considerable proportions
(15%) of Chaf1a bound ERVs are also enriched for the active
H3K4me3 modification (Figure 4C). Furthermore, Chaf1a-
bound ERVs exhibit higher levels of H3K4me2 and H3K9Ac
(Figure S4H). This raises the possibility that additional acces-
sory proteins may be required for Chaf1a to exert the silencing
effects. Notably, Sumo2-targeted ERV loci are associated with
elevated H3K9me3 levels and reduced levels of H3K4me3
modification. This binding pattern strongly resembles that of
Zfp809 and Trim28 (Figure 4C). In contrast, the non-ERV loci
bound by Chaf1a were enriched with abundant H3K4me3
marks and had no trace of H3K9me3 modifications. On the
other hand, Sumo2/Trim28/Zfp809-bound loci exhibit detect-
able but low levels of H3K9me3 (Figure 4D). Collectively, this
indicates differing modes of regulation by which individual fac-
tors control ERVs and non-ERV targets (Figures 4C, 4D, and
S3C).
To determine the action of Chaf1a and Sumo2, we repre-
sented ERV loci bound by these factors in Venn diagrams. We
found that Trim28 binds 56% of Chaf1a-bound sites, while
57% of Chaf1a ERVs are also targets of Sumo2 (Figure 4E).
Moreover, only 31% of Chaf1a ERV loci are enriched for
Zfp809 (Figure S4I). In contrast, 77% of Trim28 targets and
73% of Eset-bound ERVs are accompanied by enrichment of
Sumo2 (Figures 4E and S4I). When we extend the analysis to
three factors, we observed that more than 80% of Chaf1a/
Trim28 and Chaf1a/Eset common targets have Sumo2 binding
(Figure 4F). These observations strongly suggest a possible
role of Sumo2 in Trim28/Eset ERV regulation. The co-regulation
of Chaf1a and Sumo2 with the canonical Zfp809/Trim28/Eset
machinery seems to be ERV-specific as very little overlap was
observed between the factors on non-ERV loci (Figure S4J).
Collectively, in terms of ERV regulation, Chaf1a binding is clus-
tered away from the Sumo/Zfp809/Trim28/Eset axis (Figures
4G, 4H, and S4K). This is remarkably similar to the pattern
observed from the RNA-seq data (Figure 3D). Overall, our ChIP
data provides the first biochemical demonstration that a histone
chaperone and a sumoylation modification protein can exert
direct regulation of genomic ERVs.
Sumo2 Orchestrates the Viral Silencing Activities of
Trim28 through Its Sumoylation Modification
Our genome-wide siRNA screen identified Sumo2, and not
Sumo1 or Sumo3, to have a distinct role in proviral silencing (Fig-
ures S5A–S5C). The global RNA-seq and ChIP-seq data further
suggest that Sumo2 may repress proviruses and ERVs through
modulation of the Trim28/Eset machinery (Figure 5A). To test
this possibility, we first performed Sumo2 ChIP-qPCR and iden-
tified its binding on the proviral LTR. Importantly, when Trim28
was knocked-down, the level of Sumo2 binding on both proviral
elements and most of the ERVs tested was drastically reduced
(Figures 5B and 5C). In contrast, enrichment of Sumo2 was not
Figure 4. Direct Recruitment of Chaf1a and Sumo2 to Genomic ERVs
(A) Heatmap indicating the recruitment of Sumo2, Trim28, Zfp809, and Chaf1a on the indicated ERVs of different classes (I–III) and Line/Sine elements (LS). ChIP-
seq was performed for the indicated factors, Smad3 is used as a control. Red indicates binding whereas black indicates the absence of binding.
(B) Heatmaps of Chaf1a enrichment at the genomic regions flanking MER67C and MMERVK10c-int (left panels) and Sumo2 enrichment at the genomic regions
flanking RLTR6 and ETnERV3-int (right panels).
(C) Heatmaps of histone modifications at the genomic regions of the ERV loci bound by Chaf1a, Sumo2, Trim28, and Zfp809. The heatmaps are clustered
according to the enrichment profile of H3K4me3.
(legend continued on next page)
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Figure 5. Sumo2 Regulates Proviruses by
Post-translational Modification of Trim28
(A) Venn diagrams demonstrating the number of
common and uniquely-bound ERV loci among the
indicated factors. Sumo2 interacts extensively
with the factors from the canonical pathway. Per-
centage values indicate uniquely bound sites.
(B–D) Sumo2 functions through Trim28 in proviral
silencing. Sumo2 and Trim28 ChIP experiments
were conducted on the samples with depletion of
Sumo2 or Trim28. The enrichment was measured
by qPCR. Data is presented as mean ± SEM from
independent replicate experiments.
(E) Trim28 is modified by Sumo2 in vivo. A 3xFlag
tag was added to the 50 end of Sumo2 genomic
region using CRISPR/Cas in E14 cells. Two ho-
mozygous lines were selected for the immuno-
precipitation assays. NEM was added to protect
the sumoylated proteins from desumoylation by
SENPs in the cell lysates.
(F) Venn diagrams demonstrating the number of
common and uniquely-bound ERV loci among
indicated factors. The majority of the Trim28/
H3K9me3 enriched ERVs are also bound by
Sumo2. Percentage values indicate uniquely-
bound sites.
(G and H) Knockdown of Sumo2 and Trim28
significantly reduced the H3K9me3 enrichment on
proviral PBS and ERVs. H3K9me3 ChIP was per-
formed on the samples with depletion of Sumo2 or
Trim28. Data is presented as mean ± SEM from
independent replicate experiments.
(I) Knockdown of Trim28 and Sumo2 increased the
active H3K4me3 mark on proviral elements.
H3K4me3 ChIP was performed on samples with
depleted Sumo2 or Trim28. Data is presented as
mean ± SEM from independent replicate experi-
ments.
See also Figure S5.affected by Chaf1a knockdown (Figures S5D and S5E). Further-
more, the removal of Sumo2 abolished the binding of Trim28 at
the LTR (Figure 5D).
To interrogate whether Sumo2 directly targets Trim28 for su-
moylation, we studied well characterized 3xFlag-Sumo2 E14
cells generated using CRISPR/Cas technology (Figures S5F–(D) Enrichment of several histone marks at the genomic regions of the non-ERV loci that are bound by indicate
according to the enrichment profile of H3K4me3.
(E and F) Venn diagrams demonstrating the number of commonly and uniquely-bound ERV loci among the ind
bound sites.
(G) UCSC genome browser screenshots. Chaf1a, Sumo2, Trim28, and Zfp809 bind ETnERV3-int-ERVK, wh
and Trim28. Both ERVs are enriched with H3K9me3.
(H) Clustering analysis of the ERVs bound by the indicated factors. The color intensity signifies strength of co
yellow indicates weak correlation.
See also Figure S4 and Table S4.
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the pull-down of sumoylated proteins
(Figure 5E).
Venn diagram analysis of ChIP-seq
data indicates that 90% of Sumo2/
Trim28-bound ERV sites are marked with H3K9me3 modifica-
tions (Figure 5F). Trim28 is known to mediate the recruitment
of Eset, which in turn deposits the repressive H3K9me3 mark
at the proviral LTR (Matsui et al., 2010). Consistently, Sumo2
knockdown resulted in concomitant reduction in H3K9me3
marks and elevation of H3K4me3 modifications at the provirald factors. The reads in the heatmaps are clustered
icated factors. Percentage values indicate uniquely
ile IAP-d-int/ERVK is bound specifically by Sumo2
rrelation. Red indicates strong correlation, whereas
Figure 6. Differential Regulation of Class I, II, and III ERVs by Chaf1a
(A) Venn diagrams demonstrating the number of common and uniquely-bound ERV loci among Chaf1a, Trim28, and H3K9me3. Percentage values indicate
uniquely-bound ERVs.
(legend continued on next page)
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elements and ERVs to levels that are comparable with that seen
upon Trim28 knockdown (Figures 5G–5I).
Chaf1a Has Differential Regulatory Roles on Class I, II,
and III ERVs
Venn diagram analysis on ERVs bound by Chaf1a, Trim28, and
those associated with the H3K9me3 modification revealed that
about 64% of ERVs co-bound by Chaf1a and Trim28 are en-
riched with H3K9me3 (Figure 6A). In comparison, only 23% of
Chaf1a/Trim28 bound non-ERV loci are marked with H3K9me3
(Figure S6A). This concurs with the notion that Chaf1a and
Trim28 exert ERV-specific repressive functions. In particular,
there are significant numbers of ERVs co-bound by Chaf1a
and Trim28, or exclusively bound by Chaf1a that are not marked
with H3K9me3, suggesting that Chaf1a may adopt alternative
repressive mechanisms on these ERVs. To this end, we classi-
fied the ERVs into four categories, namely, those bound by
Chaf1a+Trim28+H3K9me3, Chaf1a+Trim28, Chaf1a only, and
Trim28 only (Table S5). Interestingly, the Chaf1a only category
has the highest percentage of class III ERVs (Figure 6B), while
the Chaf1a+Trim28+H3K9me3 category primarily belong to
class I and class II ERVs (Figure 6B). Consequentially, the dot
plots (Figures 6C and S6B) correlating ERV upregulation and
the enrichment of histonemarks further highlighted the low levels
of H3K9me3 on Chaf1a-regulated class III ERVs.
Specific class III ERVs are highly expressed in early embryonic
development and downregulated at the morula and blastula
stages. Histone demethylase Kdm1a (Macfarlan et al., 2012)
and H3K9 dimethyl transferase G9a are the key epigenetic reg-
ulators of these ERVs (Leung et al., 2011; Maksakova et al.,
2013). It was found that Kdm1a and histone deacetylase
Hdac1/2 cooperatively contribute to transcriptional silencing
(Shi et al., 2004). Hdacs have been shown to repress MERVL in
concert with Kdm1a in pluripotent stem cells (Macfarlan et al.,
2011; Reichmann et al., 2012). Interestingly, Kdm1a is one of
the candidate hits in our siRNA screen (Table S1). To further
dissect the mode of ERV regulation within each of the four cate-
gories, we integrated our Chaf1a and Trim28 ChIP-seq data with
datasets for epigenetic factors, such as Kdm1a and Hdac1/2.
Surprisingly, the ERVs from the Chaf1a only category display
the highest enrichment of Kdm1a and Hdac1/2 in comparison
to the other categories (Figures 6D and 6E). In contrast, the
ERVs bound by Chaf1a+Trim28+H3K9me3 exhibit low levels of
Kdm1a and Hdac1/2 binding (Figures 6D–6F and S6D). Consis-
tently, the Chaf1a only category is characterized by significantly
higher levels of H3K4me2, H3K9Ac, and H3K27Ac marks, which(B) Percentage stacked columns demonstrating the classes of ERVs bound by th
(C) The correlation between the upregulation of the different classes of ERVs upo
using shChaf1a RNA-seq and H3K9me3 ChIP-seq. Grey, orange, and yellow do
respectively. Black dots indicate the non-regulated ERVs.
(D) Average binding profiles of the individual categories shows that ERVs belong
Kdm1a and Hdac2 in comparison to the other categories.
(E) Enrichment of H3K9me3, Kdm1a, and Hdac2 in the genomic regions of the in
enrichment profile of H3K9me3.
(F) UCSC genome browser screenshots of representative repeat elements. RM
contrast, ORR1B2 is bound by Chaf1a, Trim28, Hdac2, and Kdm1a with very lo
absence of Trim28 and H3K9me3, while LTRIS5 is bound exclusively by Trim28.
See also Figure S6 and Table S5.
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and S6C).We further performed ERV expression analysis using a
published mESC Kdm1a knockdown RNA-seq dataset (Agarwal
et al., 2015). Kdm1a knockdown resulted in mostly class I and III
ERV upregulation, in amanner similar toChaf1a knockdown (Fig-
ure S6E). In terms of ERVs regulated, Kdm1a/Chaf1a knock-
down has 80% more overlap than Kdm1a/Trim28 knockdown
(Figures S6F and S6G). Overall, our data indicates that Chaf1a
regulates class I, II, and III ERVs through vastly different mecha-
nisms, which may depend on the co-regulators.
Chaf1a Represses Proviruses through Epigenetic
Co-factors
Chaf1a is the core component of the chromatin assembling fac-
tor complex (Caf1) that also includes Rbbp4. Interestingly, only
Chaf1a/b exhibited a proviral silencing function, while the knock-
down of Rbbp4 had no effect (Figures S7A and S7B). Moreover,
our siRNA screen did not uncover other histone chaperones
necessary for retroviral silencing, further highlighting the speci-
ficity of Chaf1a/b in this process (Figure S7B). To further
delineate the function of Chaf1a, we performed a pull-down of
Flag-tagged Chaf1a followed by stable isotope labeling using
amino acids (SILAC)-based quantitative mass spectrometry
(MS) analysis (Figure 7A). The complete list of Chaf1a-interacting
proteins includes several knownand unknown factors (Figure 7A;
Table S6). Chaf1a has previously been shown to interact with
chromatin modifying factors (Quivy et al., 2004; Sarraf and
Stancheva, 2004). Indeed, we identified several epigenetic mod-
ifiers that appeared in both the Chaf1a MS and genome-wide
siRNA screen list, such as Kdm1a, Smarcc1, and Eset. Using
co-immunoprecipitation (coIP), we confirmed the interaction
of Chaf1a with histone methyltransferase Eset, histone de-
methylase Kdm1a, deacetylase Hdac2, and histone chaperones
Chaf1b (Figures 7B–7D, S7C, and S7D).
To investigate the direct effects of Chaf1a at provirus loci, we
used the Chaf1a-3xHA CRISPR F9 cell line for ChIP-qPCR anal-
ysis. We observed direct localization of Chaf1a to the proviral
LTR elements (Figure 7E), which was further confirmed by
Chaf1a-V5 ChIP (Figure S7E). To address the relationship be-
tween Chaf1a and Trim28, we performed ChIP on Trim28 upon
Chaf1a knockdown. The binding of Trim28 was significantly
abolished by the knockdown of Trim28 itself, whereas Chaf1a-
knockdown elicited no effect (Figure S7F). This suggests that
Trim28 recruitment to the provirus is independent of Chaf1a.
Moreover, we did not detect any change in Chaf1a enrichment
upon Sumo2 depletion (Figure S7G).e indicated categories on the x axis.
n Chaf1a depletion and the enrichment of H3K9me3 mark. The data is plotted
ts represent ERVs with significantly increased expression in class I, II, and III,
ing to the Chaf1a only and Chaf1a+Trim28 categories are highly enriched with
dicated categories. The reads in the heatmaps are clustered according to the
ER16-int bound by Chaf1a and Trim28 is highly enriched with H3K9me3. In
w H3K9me3 enrichment. Chaf1a, Hdac2, and Kdm1a bind RLTR11B with the
Figure 7. Chaf1a Are Enriched at Proviruses and Regulates Their Expression through Its Interacting Epigenetic Co-factors
(A) SILAC mass spectrometry (MS) analysis uncovers the Chaf1a interactome network. Upper panel: schematic representation of the SILAC MS work-flow as
described in the supplemental procedures. Lower panel: differential protein identification in Flag-tagged Chaf1a immunoprecipitation. Several epigenetic and
chromatin regulators are indicated.
(B–D) Western blots confirm the interacting proteins identified by MS. Western blots showing co-immunoprecipitation (coIP) of Chaf1a with Eset, Kdm1a, and
Hdac2.
(E) Chaf1a is enriched at the proviral elements. Chaf1a-3xHAChIP was carried out in F9 Chaf1a-3xHA cell line using a HA antibody. The enrichment was analyzed
by qPCR. Data are presented as mean ± SEM from independent replicate experiments.
(legend continued on next page)
Cell 163, 230–245, September 24, 2015 ª2015 Elsevier Inc. 241
To understand the mechanisms by which Chaf1a silences the
newly introduced proviruses, we performed ChIP on the Chaf1a
interacting histonemodifiers Kdm1a and Hdac2. To our surprise,
both Kdm1a and Hdac2 were enriched at the proviral LTR (Fig-
ures 7F and 7G). In addition, consistent with the siRNA screen,
shRNA knockdown of Kdm1a was able to rescue the expression
of MMLV-Gfp reporter (Figure S7H). Treatment of E14 cells using
the Hdac inhibitor TSA also relieved silencing of the MMLV-Gfp
reporter (Figure S7I). Next, we tested the dynamic changes of
the histonemarks on the provirus LTR and ERVs upon the deple-
tion ofChaf1a. The enrichment of H3K9me3 on provirus LTRwas
slightly reduced (Figure 7H), while the active H3K4me3 and total
H3Ac marks were significantly increased (Figures 7I, 7J, and
S7J–S7L). Together, our data shows that the repressive function
of Chaf1a on proviruses is reinforced by the presence of its inter-
acting partners, Kdm1a, Hdac2, and Eset.
To test whether Chaf1a can directly bind the viral DNA, we per-
formed electrophoretic mobility shift assays (EMSA). We did not
observe a specific EMSA band for the Chaf1a protein, indicating
that Chaf1a does not bind directly to the viral DNA (Figures S7M–
S7O). The Caf1 complex is thought to assemble histones H3/H4
during DNA replication and repair (Gaillard et al., 1996; Kaufman
et al., 1995). Other studies have indicated that histone chaper-
ones Asf1a/b work synergistically with Caf1 (Tyler et al., 1999).
Our proteomics data also identified Asf1a/b as components of
the Chaf1a interactome (Figure 7A), and the interaction between
Chaf1a and Asf1a/b was confirmed by coIP (Figure S7P).
To further test the function of histone assembly on proviral
silencing, we performed single and combinatorial shRNA knock-
down of Asf1a/b. Surprisingly, combinatorial depletion of Asf1a/
b induced strong Gfp reactivation to a level comparable to that
observed following Chaf1a depletion (Figure S7Q), indicating
functional redundancy between Asf1a and Asf1b. This data sub-
stantiates a possible role of histone assembly in the silencing of
proviral elements and ERVs.
DISCUSSION
Mammalian genomes are cluttered with endogenous viral ele-
ments, vestiges of the long history of coevolution with retrotrans-
posons that have shaped the genome. Complex mechanisms
have evolved tomanage these elements, restricting their expres-
sion and reactivation. Silencing of retroviruses also played a
fortuitous role in the development of somatic cell reprogramming
by transcription factors, as extinction of the reprogramming
transgenes that occurs when fibroblasts revert to a pluripotent
state is essential for the induced pluripotent stem cells to avoid(F and G) Localization of Kdm1a and Hdac2 on proviral DNA. ChIP was performe
qPCR.
(H–J) The perturbation of histone mark enrichment on proviral elements upon th
performed on the samples upon depletion of Chaf1a. Data are presented as mea
(K) Schematic model for the silencing mechanism of the proviruses in mESCs invo
and its upstream histone chaperones Asf1a/b promote the deposition of histone
proviral chromatin is reinforced by the enzymatic activities of Chaf1a-interacting
Eset. This results in reduced acquisition of activating H3K4me3 and H3Acmarks.
onto the proviral DNA, in turn resulting in the deposition of the repressive H3K9m
See also Figure S7 and Table S6.
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entiation potential (Takahashi and Yamanaka, 2006). Our work
provides insights into the role of the histone chaperone Chaf1a
and sumoylation factor Sumo2 in the silencing of exogenous
proviruses and ERVs. It supports amodel whereChaf1a promote
the deposition of histone H3/H4, thus marking the integrated
proviral DNA for silencing, helping to localize the Chaf1a protein
to the viral LTR region (Figure 7K). The binding and transcriptional
repression of the proviral chromatin by Chaf1a is further rein-
forced via the enzymatic activities of Chaf1a-interacting proteins
Eset, Kdm1a, and Hdac1/2, which modify proviral chromatin
with the repressive histonemarkH3K9me3and reduce theacqui-
sition of activating H3K4me3 andH3Acmarks (Figure 7K). In par-
allel, Sumo2 is required to play critical roles in the canonical
Zfp809/Trim28/Eset complex via post-translational sumoylation
of Trim28. Sumoylation enhances the recruitment of Trim28 to
the proviral DNA, which in turn results in the modification of pro-
viral chromatin with repressive histone H3K9me3 marks (Fig-
ure 7K). Our unbiased screen for factors involved in proviral
silencing has thus revealed a complex set of genetic and epige-
netic mechanisms by which exogenous proviruses and ERVs
are transcriptionally silenced in pluripotent stem cells.
Cross-Talk between the Sumoylation Pathway and the
Canonical Complex
Among the Sumo2-related candidates, Senp6 deconjugates
Sumo2 from targeted proteins (Mukhopadhyay and Dasso,
2007), while the other factors are involved in covalent attachment
of Sumo2 to the targeted proteins (Desterro et al., 1999; Geiss-
Friedlander and Melchior, 2007; Gong et al., 1999; Hay, 2005;
Johnson, 2004; Zhao, 2007). As such, it is tempting to speculate
that the modification of key determinants by sumoylation or de-
sumoylationmay affect their capacity to silent the proviruses and
ERVs. The cross-talk between chromatin modifying complex
subunits (such as Trim28, Atf7ip, and Eset) and sumoylation fac-
tors can be inferred from the overlap of target ERVs observed, as
well as their close protein-protein interactions. Importantly, our
study clarifies the mechanism by which Sumo2 targets the pro-
viral elements and ERVs—through the sumoylation of Trim28.
Furthermore, Sumo modification on other epigenetic factors
may potentially help mediate heterochromatin formation. It will
be of great interest to determine the proteome-wide set of su-
moylated proteins in ESCs.
Regulation of Different Classes of ERVs
Our RNA-seq analysis indicates that Chaf1a/b and sumoylation
factors regulate different families of ERVs. Localization of Chaf1ad using antibodies against Kdm1a or Hdac2 and the enrichment was tested by
e depletion of Chaf1a in F9 cells. H3K9me3, H3K4me3, and H3Ac ChIP were
n ± SEM from independent replicate experiments.
lving Chaf1a, Sumo2, and the canonical Zfp809/Trim28/Eset pathway. Chaf1a
H3/H4 to mark the integrated proviral DNA. Transcriptional repression of the
proteins, including the members of the NuRD complex (Kdm1a, Hdac1/2) and
In parallel, Sumo2 sumoylates Trim28, which is necessary for recruiting Trim28
e3 mark.
and Sumo2 at ERV loci was confirmed by ChIP-seq analysis. It
is noteworthy that the pattern of the ERVs regulated by Chaf1a
is distinct from that of the sumoylation machinery or chro-
matin-modifying factors (Trim28, Eset, and Zfp809). Interest-
ingly, Chaf1a regulates a significant number of ERVs from class
III that are not marked with H3K9me3, but instead are enriched
for H3K4me2 and H3K27Ac. Moreover, Chaf1a works with the
enzymatic epigenetic modifiers, including Kdm1a and Hdac2
at these class III ERVs. In addition, Chaf1a also cooperates
with Trim28 to repress the ERVs by reinforcing high levels of
the H3K9me3 on class I and II ERVs. Thus, our study highlights
how a chaperone like Chaf1a regulates different classes of
ERVs through distinct interacting co-factors.
Suppressive Function of Histone Chaperone Chaf1a/b
on Newly Integrated Proviruses
Caf1 has been reported to have diverse functions, including
epigenetic regulation, DNA damage repair, and DNA replication
(Green and Almouzni, 2003; Kaufman et al., 1995; Poleshko
et al., 2010; Shibahara and Stillman, 1999). More recently,
Chaf1a was shown to be critical for maintaining the heterochro-
matin state through its interaction with HP1, MBD1, and Eset
(Murzina et al., 1999; Reese et al., 2003; Sarraf and Stancheva,
2004). In fact, protein structure analysis of Chaf1a indicates a
PXVXL pentapeptide motif at the N terminus, which allows
Chaf1a to specifically interact with the HP1 chromo shadow
domain (Thiru et al., 2004). Stable association of Chaf1a with
HP1 proteins may lead to its retention in heterochromatin (Mur-
zina et al., 1999). HP1 proteins are ‘‘readers’’ of repressive
H3K9me3 marks and interact extensively with Eset. Intriguingly,
our proteomics identified Eset, HP1a, HP1b, and HP1ɣ among
the Chaf1a interactome. Remarkably, only the knockdown of
Chaf1a/b was capable of rescuing the viral reporter, but not
the knockdown of Rbbp4 (Figures S7A and S7B). Previous
studies suggest that Rbbp4 complexes with Chaf1a/b in G1
phase. Notably, the epigenetic modification brought about by
Chaf1a through HP1 or Caf1/Mbd1/Eset is S-phase-specific
(Quivy et al., 2004; Sarraf and Stancheva, 2004).
How does a histone chaperone like Chaf1a localize to the
proviral LTR and ERVs? Previous work has localized histone
chaperones such as Hira and Daxx to the genomic sites where
histones are deposited (Banaszynski et al., 2013; Elsa¨sser
et al., 2012). A recent publication also described the role of his-
tone variants H3.3 in regulating ERVs (Elsa¨sser et al., 2015).
Indeed, our Chaf1a ChIP-seq shows the enrichment of Chaf1a
at the genomic sites of downstream ERV targets. When
we knockdown the upstream histone chaperones of Chaf1a
(Asf1a/b), we observed the abolishment of the viral silencing
effect of Chaf1a. Thus, we speculate that its nucleosome as-
sembly function may play a role in localizing Chaf1a to the in-
tegrated proviruses.
In conclusion, our work reveals the genome-wide compen-
dium of players that mediate proviral silencing in mouse ESCs.
Multiple pathways and multi-layered machineries are employed
by pluripotent embryonic stem cells to maintain the silencing of
proviruses and ERVs. Further studies aimed at dissecting the
intricate mechanisms by which the various factors act will help
fill the remaining gap in our understanding of proviral repression.EXPERIMENTAL PROCEDURES
Genome-wide siRNA Screen
F9 cells were seeded at 6 3 105/well in 6-well tissue culture plates. Twelve
hours later, MMLV virus was added into the wells with 8 mg/ml polybrene
(107689, Sigma). Eight hours later, F9 cells were trypsinized into single cells
and seeded onto individual well of 384-well plates (REF 781091, Greiner)
that were pre-printed with Mouse siGENOME SMARTpool library (G-015000,
Thermo Scientific Dharmacon) and contain DharmaFECT 1 (Thermo Scienti-
fic). Four days later, cells were fixed with 4% paraformaldehyde and cell nuclei
were stained with Hoechst 33342 (Invitrogen). Images were acquired using the
ImageXpress Ultra Confocal High Content Screening System (Molecular De-
vices). Gfp signal was quantified by the MetaXpress software (Molecular De-
vices). Both the siRNA screens were carried out in duplicates. The average
of the duplicate Gfp signal was calculated by normalizing to both positive
and negative controls using ScreenSifter software (Kumar et al., 2013). A
cut-off threshold was set at value >2 SD frommean of negative controls, above
which siRNA of 650 candidate genes significantly increase Gfp expression
level. Based on the secondary screening, 303 high-confidence hits with Gfp
signal (CtrlNorm value = (X  Avg(xcn))/(Avg(xcp)  Avg(xcn)) cut off above
0.45 were selected.
RNA-Sequencing
Total RNA was extracted as described in the Supplemental Experimental Pro-
cedures. DNA contamination was removed using a QIAGEN RNeasy Kit.
The RNA samples were subject to mRNA selection, fragmentation, cDNA
synthesis, and library preparation using a TruSeq RNA Sample Prep Kit (RS-
122-2001, Illumina). Library quality was analyzed on a Bioanalyzer. High-
throughput sequencing was performed on the Genome Analyzer IIx (Illumina).
ChIP and ChIP-Seq Assay
Chromatin was prepared according to the methods provided in the Supple-
mental Experimental Procedures. Chromatin extracts were immunoprecipi-
tated using H3K4me3 (Abcam), H3Ac (Abcam), H3K9me3 (Abcam), Eset
(Abcam), Trim28 (Bethyl), Sumo2 (Abcam), and HA (Santa Cruz) antibodies.
Input and immunoprecipitation samples were analyzed by qPCR. All primers
used are listed in Table S7. ChIP-seq libraries were prepared according to
manufacturer’s instructions (Illumina). High-throughput sequencing was per-
formed on a Genome Analyzer IIx (Illumina).
Bioinformatics Analysis
See detailed information in the Supplemental Experimental Procedures.
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Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
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